Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Watertown, MA, 2023-Jan-29 — /EPR Network/ — Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody [read full press release…]